Atopic dermatitis (atopic eczema) is a chronic relapsing and remitting inflammatory skin
disease affecting one in 10 people in their lifetime. Atopic dermatitis is caused by a complex …

Staphylococcus aureus is frequently isolated from the skin of atopic dermatitis (AD) patients
during flares. The normal microbiota is disrupted and the diversity of the microorganisms on …

Dupilumab is a fully human antibody to interleukin-4 receptor α that improves the signs and
symptoms of moderate to severe atopic dermatitis (AD). To determine the effects of …

Objective Atopic dermatitis (AD) is a chronic inflammatory skin disease that is complicated
by an increased risk for skin and systemic infections. Preventive therapy for AD is based on …

Background Atopic dermatitis (AD) is characterized by skin barrier defects, T helper type 2
cell activation, and increased risk for cutaneous and extracutaneous infections. In clinical …

Atopic dermatitis (AD) is a chronic inflammatory skin disorder that affects a substantial
number of children and has a significant negative impact on affected patients and their …

Atopic dermatitis (AD) is characterized by severe pruritus and recurrent eczema with a
chronic disease course. Impaired skin barrier function, hyperactivated TH 2 cell–type …

The accessory gene regulator (agr) quorum-sensing system is arguably the most important
regulator of Staphylococcus virulence. The agr-system serves a crucial role in pathogenesis …

Background/Purpose Atopic dermatitis (AD) is a chronic inflammatory disease commonly
seen in children and increasingly recognized in adults. With recent advances in the …

Abstract Supercritical CO 2 (scCO 2) technology is used here as an efficient method to assist
in the preparation of a cutaneous polymeric formulation based on drug containing metal …